Serum creatine phosphokinase activity in psychiatric patients receiving electroconvulsive therapy

Taylor, Pamela Jane ORCID: https://orcid.org/0000-0002-3998-6095, von Witt, R.J. and Fry, A. 1981. Serum creatine phosphokinase activity in psychiatric patients receiving electroconvulsive therapy. Journal of Clinical Psychiatry 42 (3) , pp. 103-105.

Full text not available from this repository.

Abstract

Elevation of serum creatine phosphokinase (CPK) has been demonstrated in patients with organic brain pathology. It has been alleged that electroconvulsive therapy (ECT) produces significant brain damage. In a group of patients receiving ECT, the levels remained within normal limits although a small rise in skeletal muscle type CPK was demonstrated following treatment. In no case was any brain type CPK isolated

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Physicians Postgraduate Press, Inc
ISSN:	0160-6689
Last Modified:	31 Oct 2022 10:36
URI:	https://orca.cardiff.ac.uk/id/eprint/85437

Citation Data

Cited 5 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item